Subject title: GICI NZ: Call for Applications – Part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship
The GI Cancer Institute NZ is calling for applications for:
Part time GI Cancer Clinical Fellowship
The GI Cancer Institute NZ offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year supported by the Hugh Green Foundation. The Fellowship is for the support of outstanding graduates from all relevant health professions, who are able to combine their clinical work with research to improve the quality of life and potential survival for people living with a GI cancer.
The Fellowship is tenable for a period of up to three years. Applications are open to appropriately qualified individuals with New Zealand residency, permanent residency or citizenship, who hold a relevant degree or are in the process of completing their training.
The GI Cancer Clinical Fellowship would be available in (but not limited to) the speciality areas of cancer surgery, radiation oncology, medical oncology, palliative care, cancer genetics, radiology, anatomical pathology, nutrition, psychiatry or public health.
The salary will be the equivalent to the appropriate level of remuneration of the applicant’s current employment. Please provide evidence of your current salary per annum. The Institute will provide a contribution towards working expenses of $5,000 per annum. The Institute has a total of $45,000 per annum for remuneration of salary costs only.
All recipients would be expected and required to acknowledge funding support from GICI and the Hugh Green Foundation in oral or written reports about their work. The successful applicant must be prepared to have a profile posted on GICI’s website www.gicinz.org.nz and promoted through GICI’s marketing material. Six monthly progress reports are required using the provided accountability template.
Applications must be received by GICI NZ by email to email@example.com by 5 pm, 1st October 2016. Please note that your host institution may have an earlier closing date and GICI NZ strongly encourages you to adhere to the internal deadline. Please also ensure that you also fulfil any institutional requirements for submission.
The decision will be made by GI Cancer Institute’s Scientific Advisory Committee and ratified by the GI Cancer NZ board of directors. Applicants will be notified by of the final decision by 1st November 2016.
See information about GICI NZ below.
GI Cancer Institute Executive Officer
The Gastro-Intestinal Cancer Institute (GICI) is a charity dedicated to improving outcomes of gastro-intestinal (GI) cancer including quality of life and improved survival rates. This group of cancers affect the bowel, pancreas, stomach, gallbladder, liver, and oesophagus. It’s collectively the most common form of cancer in New Zealand, with nearly 5,000 people diagnosed each year. Yet despite its prevalence, GI cancer remains under-represented in awareness and funding. We seek to make a difference by funding clinical research and raising the public profile of GI cancer.
GICI’s primary goal is to fund clinical research trials in New Zealand. Clinical trials are the final link in the chain of medical research that take discoveries made in the laboratory and advance them into treatments that can save lives. By participating in clinical trials, patients gain the benefits of early access to leading-edge treatments and their specialists have the opportunity to provide research-driven care, which is care of the highest quality.
We raise funds and award grants to hospitals running clinical trials our experts believe will offer the potential to significantly improve treatments for patients with GI cancer.
The most recent release of the NZ Ministry of Health Cancer Statistics, 4916 New Zealanders were diagnosed with a gastro-intestinal cancer. That’s 13.5 people a day.
In 2012, 2714 New Zealanders died from a gastro-intestinal cancer. That’s 7.5 people a day. Over half of the people diagnosed with gastro-intestinal cancers will die within 5 years of diagnosis.
Clinical Research Fellowship in Gastro-Intestinal Cancer
There is a clear need for a better understanding of GI cancers, how and why they develop, how they present and how they are best treated. Despite implementing optimal treatment for these cancers there is still an urgent need for new advances to improve the survival odds.
Publicly-funded health services are obliged to concentrate their scarce resources on doing the basics of getting known treatments to the right people, at the right time and to an appropriate level of quality. In cancer this can be mapped along the patient experience e.g. prevention, screening, diagnosis, treatment, rehabilitation and palliative care.
In order to future-proof the health of the community however, health services need research that will generate new knowledge to ensure they provide, not just best care today but better care for tomorrow.